Improvement in Lipids after Switch to Boosted Atazanavir or Darunavir in Children/adolescents with Perinatally Acquired HIV on Older Protease Inhibitors: Results from the Pediatric HIV/AIDS Cohort Study

J. Jao,W. Yu, K. Patel,T. L. Miller,B. Karalius,M. E. Geffner,L. A. DiMeglio,A. Mirza,J. S. Chen,M. Silio,E. J. McFarland,R. B. Van Dyke,D. Jacobson

HIV medicine（2017）

引用 5|浏览49

暂无评分

摘要

Dyslipidaemia is common in perinatally HIV‐infected (PHIV) youth receiving protease inhibitors (PIs). Few studies have evaluated longitudinal lipid changes in PHIV youth after switch to newer PIs.

查看译文

关键词

atazanavir,children,darunavir,lipids,longitudinal,perinatally HIV-infected

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要